Loading...

Archive

    02 November 2016, Volume 32 Issue 11 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Treatment for recurrent deeply infiltrating endometriosis.
    LI Meng-hui,ZHANG Zhen-yu.
    2016, 32(11): 1038-1041.  DOI: 10.7504/fk2016100102
    Abstract ( )  

    Abstract:Recurrence is an important,common issue,and is difficult to handle in the diagnosis and treatment of endometriosis.Deeply infiltrating endometriosis has low recurrence rate,and residual lesions of previous surgery is considered to be the main reason of recurrence.Recurrent patients have massive adhesions,deeply focal invasion,increased surgical complications and difficulty for surgery,and could be technically demanding.A second surgery must be based on a detailed risk-benefit evaluation before implementation.Preoperative and postoperative evaluation and drug treatment should be stressed,and systematic management should be emphasized.

    Management of recurrent endometrioma after laparoscopic excision.
    DUAN Hua,SUN Fu-jing.
    2016, 32(11): 1041-1045.  DOI: 10.7504/fk2016100103
    Abstract ( )  

    Abstract:Endometrioma is the most common type of endometriosis.Laparoscopic excision of cyst is generally accepted as the standard surgical treatment methord.But for those recurrent patients,re-operation is not the first choice.Repeated surgery is likely to cause the further damage to ovarian tissue,and may even cause permanent loss of ovarian function.Medical treatment,ultrasound-guided aspiration or combined with sclerotherapy,as well as conservative/radical surgery should be consider as an alternative treatment option according to age of the patients,severity of the disease and fertility requirements.In a word,on the basis of the principle of initial treatment,individualized treatment and standardized operation are recommended.

    Treatment for dysmenorrhea relapse after remission following adenomyosis treatment.
    CHEN Chun-lin.
    2016, 32(11): 1045-1049.  DOI: 10.7504/fk2016100104
    Abstract ( )  

    Abstract:Adenomyosis is a kind of benign disease which is difficult to treat. Dysmenorrhea evaluation is complex,so it needs a unified standard in order to better evaluate the efficacy. This article reviewed various literature and guidelines,indicating that VAS can be used to evaluate the postoperative monthly dysmenorrhea situation. However,for analysis of long period of dysmenorrhea before and after operation, the chronic pain rating scale questionnaire can be used. Previous team studies have shown that 6 months after surgery is the time to evaluate the outcome of conservative treatment. So conservative treatment can be evaluated as no effect,remission and relapse after remission in 6 months after treatment. Concerning the efficacy of conservative treatment,different methods have their own advantages and disadvantages,and for patients who relapse after symptom relief, the use of multiple sequential comprehensive treatment may be considered.

    Management of recurrent pelvic inflammatory mass.
    GAN Xiao-ling,HU Li-na.
    2016, 32(11): 1049-1052.  DOI: 10.7504/fk2016100105
    Abstract ( )  

    Abstract:The relapse of pelvic inflammatory mass is always a difficult issue in gynecological clinic.In this paper,the risk factors,diagnosis,treatment,and prevention of the recurrent pelvic inflammatory mass were reviewed in order to improve its knowledge,and to norm its treatment,and consequently prevent its relapse.

    Management of lymphocele formation after lymphadenectomy for gynecological malignancies.
    WANG Yan-zhou,LIANG Zhi-qing.
    2016, 32(11): 1052-1057.  DOI: 10.7504/fk2016100106
    Abstract ( )  

    Abstract:Postoperative lymphocele formation is a common complication of lymphadenectomy for gynecological malignancies.Several techniques are possible to decrease the incidence of lymphocele when used in combination,such as:leaving the peritoneum open at the end of the surgical procedure,omentoplasty,postoperative octreotide therapy.However,routine postoperative drainage had no detectable benefits in most of the recent prospective studies.If the lymphocele cause pressure symptoms related to their size or location,affect the quality of life of patients or become infected,the lymphocele should be treated.Ultrasound or CT-guided percutaneous catheter drainage may be a simple and efficient method of treatment,sometimes added with sclerotization agents of Ethanol and betadine.Laparoscopic surgery also showed a good prospect in the treatment of lymphatic cyst.But the choosing of surgical approach should be combined with specific clinical circumstances and experience of the surgeon.Comprehensive analysis of individualized treatment should be considered before the surgery.

    Clinical strategies for recurrent VAIN.
    SUI Long,CHEN Li-mei.
    2016, 32(11): 1057-1060.  DOI: 10.7504/fk2016100107
    Abstract ( )  

    Abstract:The incidence rate of vaginal intraepithelial neoplasia (VAIN) showed an upward trend in recent years.VAIN is caused by the infection of HPV with multi-focus and high recurrence rate.It always coexists with cervical intraepithelial neoplasia.It’s diagnosed by colposcopically-guided punch biopsy.The current treatments include medication (5-FU or imiquimod),laser and local resection.CO2 laser vaporization is effective,safe,minimally invasive,which can be applied in treatment of recurrent VAIN.

    Problems related to the recurrence of cervical intraepithelial neoplasia.
    FENG Ding-qing,LING Bin.
    2016, 32(11): 1060-1064.  DOI: 10.7504/fk2016100108
    Abstract ( )  

    Abstract: The recurrence of high-grade cervical intraepithelial neoplasia (CIN) is a significant problem after treatment with physiotherapy,cold knife conization (CKC),or loop electrosurgical excision procedure (LEEP).The risk factors for recurrence of posttreatment CIN include incomplete resection,involved margins and glands,persistence of HPV,and immunodeficiency of cervix.Higher age at resection may be a preoperative indicator for recurrence.Close follow-up,timely diagnosis of residual lesions,expanded range of resection or hysterectomy,to some extent,well prevent the recurrence of CIN.Meanwhile,missed diagnosis and over-treatment must be avoided as much as possible.

    Diagnosis and treatment of recurrent uterine fibroids.
    FAN Wen-sheng MENG Yuan-guang.
    2016, 32(11): 1064-1068.  DOI: 10.7504/fk2016100109
    Abstract ( )  

    Abstract:The recurrence of uterine fibroids is related to many factors,including patient age,BMI,the size and numer of tumers in the former operation,times of pregnancy or delivery and the means of original treatment.The principles of treatment should be relieving symptoms and curing diseases.The follow-up,GnRH-a drug therapy and surgery are the main treatment methods.It is FIGO stage of uterine fibroids that indicates the interrelationship of the location of tumer to the endometrial,which provides the evidence for individualized treatment.Total hysterectomy is necessary when boundary tumer is suspected.

    Diagnosis and treatment problems of the recurrence of pseudomyxoma peritonei.
    DI Wen*,WANG You*.
    2016, 32(11): 1068-1071.  DOI: 10.7504/fk2016100110
    Abstract ( )  

    Abstract:Pseudomyxoma peritonei is a rare neoplastic condition that is apt to relapse.It was originally applied to intraperitoneal mucinous spread originating from a cystadenoma of the appendix. The progressive accumulation of copious amounts of mucinous fluid gradually fills the peritoneal cavity,resulting in the characteristic "jelly belly". It was also used to describe peritoneal dissemination of mucusproducing abdominopelvic adenocarcinomas.The detection and treatment of its recurrence is a challenge in clinical practice.Thus,it is necessary to strengthen multidisciplinary cooperation for improving the prognosis.

    Related factors and treatment of recurrence ovary teratomas.
    WANG Dan-bo,MA Yue.
    2016, 32(11): 1071-1075.  DOI: 10.7504/fk2016100111
    Abstract ( )  

    Abstract:Ovary teratoma is a common disease of gynecologic neoplasms in reproductive age women,8%~15%of them are bilateral growth,and 1.01% are multiple teratoma.Bilateral ovarian teratoma is positively correlated with multiple one,and the situation of postoperative recurrence is worth attention.The diameter of tumor≥8 cm,bilateral occurrence,multiple occurrence or severance are predictive risk factors for recurrence,and for a patient with more than one of these predictive factors,the recurrence rate is increased significantly.Surgery residual or new growth are main recurrence reasons.Preoperatively assessing the risk of recurrence and selecting the appropriate surgical approach can reduce the risk of recurrence and provide effective monitoring.

    Principle of dealing with recurrent endometrial hyperplasia.
    ZHANG Jian-qing.
    2016, 32(11): 1075-1079.  DOI: 10.7504/fk2016100112
    Abstract ( )  

    Abstract:In this paper,we discussed the diagnosis,monitoring method,management,treatment and other related issues based on the latest domestic and international guidelines about recurrent endometrial hyperplasia.The best conservative treatment for recurrent endometrial hyperplasia is based on endometrial histological classification,and for non-atypical endometrial hyperplasia,followed-up and oral contraceptive can be used for 6 months,or levonorgestrel-releasing intrauterine system (LNG-IUS)can be performed.For patients without fertility requirements,we recommended application of LNS-IUS for 5 years.For those that progress to atypical endometrial hyperplasia,who have no histological remission after drug therapy for 12 months or have irregular persistent uterine bleeding and those who have postmenopausal recurrent endometrial hyperplasia,hysterectomy should be performed.

    Strategy of preventing recurrence of endometrial polyps after treatment.
    ZHANG Xu-yin,HUA Ke-qin.
    2016, 32(11): 1079-1082.  DOI: 10.7504/fk2016100113
    Abstract ( )  

    Abstract:Hysteroscopic surgery is the best treatment for endometrial polyps.Blind diagnostic curettage was opposed.Hysteroscopy polypectomy combined with endometrectomy can reduce the recurrence rate,and it can also prevent endometrial polyp recurrence in the patients with breast cancer receiving tamoxifen treatment.